30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Pendarvis Christiane

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pendarvis Christiane's trades of Hims & Hers Health Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-06 2025-03-05
S Sale
4,197 +39.7%
151.58
US$1,017,193 		4,197 +39.7% 151.58 US$1,017,193
2025-03-05 2025-03-05
PrS Proposed sale
73,093
441.86
US$110,654 		73,093 441.86 US$110,654
2024-08-28 2024-08-27
S Sale
21,496 +4.4%
112.36
US$4,631,945 		21,496 +4.4% 112.36 US$4,631,945
2024-08-27 2024-08-27
PrS Proposed sale
7,000
15.15
US$106,067 		7,000 15.15 US$106,067
2024-05-14 2024-05-13
S Sale
4,000 -26.3%
12.33
US$49,320 		4,000 -26.3% 12.33 US$49,320
2024-05-13 2024-05-13
PrS Proposed sale
4,000
12.33
US$49,320 		4,000 12.33 US$49,320